Contents
Issue 163 • April 2026
In association with
In Depth
Digital twins become new CDMO focus
Physical AI rewires manufacturing
UAE's CellSave Arabia targets growth in regenerative medicine
Drugmakers prep for obesity pill boom
China’s biotech surge upends the global CDMO model
Gilead doubles down on cell therapy
Autologous versus allogeneic
2025 dominated in ALS research
Merck’s strategic shift